The DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Erythropoietin or darbepoetin for patients with cancer
Open accessAbstract
BACKGROUND: Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions. OBJECTIVES: To assess the effects of ESAs to either prevent or treat anaemia in cancer patients. SEARCH METHODS: This is an update of a Cochrane review first published in 2004. We searched the Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE and other databases. Searches were done for the periods 01/1985 to 12/2001 for the first review, 1/2002 to 04/2005 for the first update and to November 2011 for the current update. We also contacted experts in the field and pharmaceutical companies. SELECTION CRITERIA: Randomised controlled trials on managing anaemia in cancer patients receiving or not receiving anti-cancer therapy that compared the use of ESAs (plus transfusion if needed). DATA COLLECTION AND ANALYSIS: Several review authors assessed trial quality and extracted data. One review author assessed quality assessment and extracted data, a second review author checked for correctness. MAIN RESULTS: This update of the systematic review includes a total of 91 trials with 20,102 participants. Use of ESAs significantly reduced the relative risk of red blood cell transfusions (risk ratio (RR) 0.65; 95% confidence interval (CI) 0.62 to 0.68, 70 trials, N = 16,093). On average, participants in the ESAs group received one unit of blood less than the control group (mean difference (MD) -0.98; 95% CI -1.17 to -0.78, 19 trials, N = 4,715). Haematological response was observed more often in participants receiving ESAs (RR 3.93; 95% CI 3.10 to 3.71, 31 trials, N = 6,413). There was suggestive evidence that ESAs may improve Quality of Life (QoL). There was strong evidence that ESAs increase mortality during active study period (hazard ratio (HR) 1.17; 95% CI 1.06 to 1.29, 70 trials, N = 15,935) and some evidence that ESAs decrease overall survival (HR 1.05; 95% CI 1.00 to 1.11, 78 trials, N = 19,003). The risk ratio for thromboembolic complications was increased in patients receiving ESAs compared to controls (RR 1.52, 95% CI 1.34 to 1.74; 57 trials, N = 15,498). ESAs may also increase the risk for hypertension (fixed-effect model: RR 1.30; 95% CI 1.08 to 1.56; random-effects model: RR 1.12; 95% CI 0.94 to 1.33, 31 trials, N = 7,228) and thrombocytopenia/haemorrhage (RR 1.21; 95% CI 1.04 to 1.42; 21 trials, N = 4,507). There was insufficient evidence to support an effect of ESA on tumour response (fixed-effect RR 1.02; 95% CI 0.98 to 1.06, 15 trials, N = 5,012). AUTHORS' CONCLUSIONS: ESAs reduce the need for red blood cell transfusions but increase the risk for thromboembolic events and deaths. There is suggestive evidence that ESAs may improve QoL. Whether and how ESAs affects tumour control remains uncertain. The increased risk of death and thromboembolic events should be balanced against the potential benefits of ESA treatment taking into account each patient's clinical circumstances and preferences. More data are needed for the effect of these drugs on quality of life and tumour progression. Further research is needed to clarify cellular and molecular mechanisms and pathways of the effects of ESAs on thrombogenesis and their potential effects on tumour growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
(2008) · Cited by 3,790
(1989) · PubMed · Cited by 3,343
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,857
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
Carson, J. L., Grossman, B. J., Kleinman, S., Tinmouth, A. T., Marques, M. B., Fung, M. K., Holcomb, J. B., Illoh, O., Kaplan, L. J., Katz, L. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-1-201206190-00429 · Cited by 1,084
STATISTICAL ISSUES IN ECOLOGICAL META-ANALYSES
Gurevitch, J., & Hedges, L. V. (1999) · Ecology · doi:10.1890/0012-9658(1999)080[1142:siiema]2.0.co;2 · Cited by 1,081
Chapter 10: Addressing reporting biases
Egger, M., & Moher, D. (2011) · Cited by 997
Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2865 · Cited by 974
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
Groopman, J. E., & Itri, L. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1616 · Cited by 929
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
Knight, K., Wade, S., & Balducci, L. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.008 · Cited by 878
Jaime, J., Salas, M., Ward, A., & Goss, G. D. (2001) · PubMed · Cited by 844
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Bauβnann, E., Mitze, M., Knapstein, P. G., & Vaupel, P. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90025-4 · Cited by 809
Cella, D., Eton, D. T., Lai, J.-S., Peterman, A. H., & Merkel, D. E. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00529-8 · Cited by 808
Caro, J. J., Salas, M., Ward, A., & Goss, G. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12<2214::aid-cncr1251>3.0.co;2-p · Cited by 764
Demetri, G. D., Kris, M., Wade, J., Degos, L., & Cella, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3412 · Cited by 751
Expression cloning of the murine erythropoietin receptor
D'Andrea, A. D., Lodish, H. F., & Wong, G. G. (1989) · Cell · doi:10.1016/0092-8674(89)90965-3 · Cited by 738
Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731
Chapter 16: Special Topics in Statistics
Higgins, J. P. T., Deeks, J. J., & Altman, D. (2008) · Cited by 728
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003) · Cancer · doi:10.1002/cncr.11742 · Cited by 712
Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S., & Vadhan-Raj, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1218 · Cited by 693
Cella, D. F. (1997) · PubMed · Cited by 687
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 597
Self-citationGabrilove, J. L., Cleeland, C. S., Livingston, R. B., Sarokhan, B., Winer, E., & Einhorn, L. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2875 · Cited by 595
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Teicher, B. A., Lazo, J. S., & Sartorelli, A. C. (1981) · PubMed · Cited by 555
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
Self-citationHematology: Basic Principles and Practice
Peterson, L. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.3.354a · Cited by 504
Vote-counting methods in research synthesis.
Hedges, L. V., & Olkin, I. (1980) · Psychological Bulletin · doi:10.1037//0033-2909.88.2.359 · Cited by 495
Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy
VAUPEL, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90210-6 · Cited by 479
Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization
Koury, S., Bondurant, M., & Koury, M. (1988) · Blood · doi:10.1182/blood.v71.2.524.524 · Cited by 477
Vansteenkiste, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1211 · Cited by 477
Breast cancer trial with erythropoietin terminated unexpectedly
Leyland-Jones, B. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01163-x · Cited by 474
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222402 · Cited by 443
Pure Red-Cell Aplasia and Epoetin Therapy
Bennett, C. L., Luminari, S., Nissenson, A. R., Tallman, M. S., Klinge, S. A., McWilliams, N., McKoy, J. M., Kim, B., Lyons, E. A., Trifilio, S. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040528 · Cited by 437
Wright, J. R., Ung, Y. C., Julian, J. A., Pritchard, K. I., Whelan, T. J., Smith, C., Szechtman, B., Roa, W., Mulroy, L., Rudinskas, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1514 · Cited by 428
Rizzo, J. D., Lichtin, A. E., Woolf, S. H., Seidenfeld, J., Bennett, C. L., Cella, D., Djulbegovic, B., Goode, M. J., Jakubowski, A. A., Lee, S. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.177 · Cited by 417
Self-citationAuerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 414
Factors influencing quality of life in cancer patients: anemia and fatigue.
Cella, D. F. (1998) · PubMed · Cited by 386
Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Tonelli, M., Garg, A. X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00252 · Cited by 363
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports
Williamson, L. M., Lowe, S., Love, E. M., Cohen, H., Soldan, K., McClelland, D. B. L., Skacel, P., & Barbara, J. A. J. (1999) · BMJ · doi:10.1136/bmj.319.7201.16 · Cited by 335
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Österborg, A., Brandberg, Y., Molostova, V., Iosava, G., Abdulkadyrov, K., Hedenus, M., & Messinger, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.131 · Cited by 310
Transfusion Medicine — Blood Conservation
Goodnough, L. T., Brecher, M. E., Kanter, M. H., & AuBuchon, J. P. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400706 · Cited by 310
Hellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 304
Jädersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., & Hellström-Lindberg, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4906 · Cited by 300
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans
Stohlawetz, P. J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H. G., Kabrna, E., Geissler, K., & Jilma, B. (2000) · Blood · doi:10.1182/blood.v95.9.2983.009k27_2983_2989 · Cited by 293
Drug therapy for the management of cancer-related fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006704.pub3 · Cited by 283
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn250 · Cited by 283
_, _. (2007) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2007.0088 · Cited by 282
Henry, D. H., Dahl, N. V., Auerbach, M., Tchekmedyian, S., & Laufman, L. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-231 · Cited by 264
Glaser, C. M., Millesi, W., Kornek, G. V., Lang, S., Schüll, B., Watzinger, F., Selzer, E., & Lavey, R. S. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01488-2 · Cited by 263
Erythropoietin regulates tumour growth of human malignancies
Yasuda, Y. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg060 · Cited by 257
Cella, D., Kallich, J., McDermott, A., & Xu, X. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh235 · Cited by 246
Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?
Henke, M., Mattern, D., Pepe, M., Bézay, C., Weissenberger, C., Werner, M., & Pajonk, F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2737 · Cited by 240
Erythropoietin and erythropoietin receptor expression in human cancer.
Ács, G., Acs, P. I., Beckwith, S. M., et al. (2001) · PubMed · Cited by 240
Bohlius, J., Langensiepen, S., Schwarzer, G., Seidenfeld, J., Piper, M., Bennett, C., & Engert, A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji087 · Cited by 238
Self-citationGlaspy, J., Crawford, J., Vansteenkiste, J., Henry, D., Rao, S., Bowers, P., Berlin, J. A., Tomita, D., Bridges, K., & Ludwig, H. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605498 · Cited by 237
LUDWIG, H. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90206-4 · Cited by 234
Seidenfeld, J., Piper, M., Flamm, C., Hasselblad, V., Armitage, J. O., Bennett, C. L., Gordon, M. S., Lichtin, A. E., Wade, J. L., Woolf, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1204 · Cited by 222
Self-citationKoury, S., Bondurant, M., Koury, M., & Semenza, G. (1991) · Blood · doi:10.1182/blood.v77.11.2497.2497 · Cited by 221
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
Becker, A., Stadler, P., Lavey, R. S., Hänsgen, G., Kuhnt, T., Lautenschläger, C., Feldmann, H. J., Molls, M., & Dunst, J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00384-3 · Cited by 218
Methodologic issues in assessing the quality of life of cancer patients
Aaronson, N. K. (1991) · Cancer · doi:10.1002/1097-0142(19910201)67:3+<844::aid-cncr2820671416>3.0.co;2-b · Cited by 211
Smith, R. E., Aapro, M. S., Ludwig, H., Pintér, T., Šmakal, M., Ciuleanu, T. E., Chen, L., Lillie, T., & Glaspy, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2885 · Cited by 211
Knocke, T.-H., Weitmann, H.-D., Feldmann, H.-J., Selzer, E., & Pötter, R. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00139-5 · Cited by 210
Blood Transfusion-Induced Immunomodulation
Landers, D. F., Hill, G. E., Wong, K. C., & Fox, I. J. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199601000-00035 · Cited by 209
Witzig, T. E., Silberstein, P. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Mailliard, J. A., Rowland, K. M., Alberts, S. R., Krook, J. E., Levitt, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.020 · Cited by 209
Galton, D. A. (1989) · BMJ · doi:10.1136/bmj.299.6699.582 · Cited by 206
Osterborg, A., Boogaerts, M., Cimino, R., Essers, U., Holowiecki, J., Juliusson, G., Jager, G., Najman, A., & Peest, D. (1996) · Blood · doi:10.1182/blood.v87.7.2675.bloodjournal8772675 · Cited by 202
Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta
Halstenson, C. E., Macres, M., Katz, S. A., Schnieders, J. R., Watanabe, M., Sobota, J. T., & Abraham, P. A. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.210 · Cited by 198
Tonelli, M., Hemmelgarn, B., Reiman, T., Manns, B., Reaume, M. N., Lloyd, A., Wiebe, N., & Klarenbach, S. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090470 · Cited by 197
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
Ludwig, H., Fritz, E., Leitgeb, C., Pecherstorfer, M., Samonigg, H., & Schuster, J. (1994) · Blood · doi:10.1182/blood.v84.4.1056.1056 · Cited by 196
Cascinu, S., Fedeli, A., Ferro, E. D., Fedeli, S. L., & Catalano, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1058 · Cited by 194
Cancer- and Chemotherapy-Induced Anemia
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0042 · Cited by 191
Epoetin alpha and beta in their erythropoetin isoform compositions and biological properties
(1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00521.x · Cited by 185
Erythropoietin for anaemia in cancer patients
Abels, R. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80281-3 · Cited by 185
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
Dammacco, F., Castoldi, G., & Rödjer, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02715.x · Cited by 181
Functional Significance of Erythropoietin Receptor Expression in Breast Cancer
Arcasoy, M. O., Amin, K., Karayal, A. F., Chou, S.-C., Raleigh, J. A., Varia, M. A., & Haroon, Z. A. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000020415.72863.40 · Cited by 175
Henry, D. H., & Abels, R. I. (1994) · PubMed · Cited by 175
Ludwig, H., & Fritz, E. (1998) · PubMed · Cited by 175
yndromes, I. T. C. O. S. T. G. R. R. I. M. Y. S. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01085.x · Cited by 174
Wilson, J., Yao, G., Raftery, J., Bohlius, J., Brunskill, S., Sandercock, J., Bayliss, S., Moss, P., Stanworth, S., & Hyde, C. (2007) · Health Technology Assessment · doi:10.3310/hta11130 · Cited by 173
Self-citationDarbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
Glaspy, J. A., Jadeja, J. S., Justice, G., Kessler, J., Richards, D., Schwartzberg, L., Tchekmedyian, N. S., Armstrong, S., O'Byrne, J., Rossi, G., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600465 · Cited by 171
The erythropoietin receptor in normal and cancer tissues
JELKMANN, W. E. B., Bohlius, J., Hallek, M. J., & Sytkowski, A. J. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.03.006 · Cited by 170
Self-citationThomas, G., Ali, S., Hoebers, F. J. P., Darcy, K. M., Rodgers, W. H., Patel, M., Abulafia, O., Lucci, J. A., & Begg, A. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.011 · Cited by 169
Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma
Ács, G., Zhang, P. J., Rebbeck, T. R., Acs, P. I., & Verma, A. M. (2002) · Cancer · doi:10.1002/cncr.10787 · Cited by 167
Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin
Leitgeb, C., Pecherstorfer, M., Fritz, E., & Ludwig, H. (1994) · Cancer · doi:10.1002/1097-0142(19940515)73:10<2535::aid-cncr2820731014>3.0.co;2-5 · Cited by 167
Vaupel, P. W., & Höckel, M. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.5.869 · Cited by 165
Cisplatin-associated anemia: an erythropoietin deficiency syndrome.
Wood, P. A., & Hrushesky, W. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117840 · Cited by 164
Deep vein thrombosis in cancer: the scale of the problem and approaches to management
Falanga, A., & Zacharski, L. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi165 · Cited by 158
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M. J., Weingart, O., Kluge, S., et al. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007303.pub2 · Cited by 155
Self-citationErythropoietin or Darbepoetin for patients with cancer
Bohlius, J., Wilson, J. S., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S. E., Brunskill, S. J., et al. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub4 · Cited by 149
Self-citationStein, R. S., Abels, R., & Krantz, S. B. (1991) · Blood · doi:10.1182/blood.v78.7.1658.1658 · Cited by 146
Ludwig, H., Crawford, J., Österborg, A., Vansteenkiste, J., Henry, D. H., Fleishman, A. N., Bridges, K., & Glaspy, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1130 · Cited by 142
Beneficial and ominous aspects of the pleiotropic action of erythropoietin
JELKMANN, W. E. B., & Wagner, K. F. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0911-6 · Cited by 139
Kotasek, D., Steger, G. G., Faught, W., Underhill, C. R., Poulsen, E., Colowick, A. B., Rossi, G., & Mackey, J. A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00456-8 · Cited by 139
Untch, M., Fasching, P. A., Konecny, G. E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H., Stickeler, E., Urbaczyk, H., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq709 · Cited by 134
Mastro, L. D., Venturini, M., Lionetto, R., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2715 · Cited by 130
Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy
Belle, S. V., & Cocquyt, V. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00093-3 · Cited by 129
Thatcher, N. J., Campos, E. S. D., Bell, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690369 · Cited by 129
Ross, S. D., Fahrbach, K. R., Frame, D., Scheye, R., Connelly, J. E., & Glaspy, J. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80170-4 · Cited by 124
Untch, M., von Minckwitz, G., Konecny, G. E., Conrad, U., Fett, W., Kurzeder, C., Lück, H., Stickeler, E., Urbaczyk, H., Liedtke, B., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq713 · Cited by 124
Erythropoietin increases hemoglobin in cancer patients during radiation therapy
Lavey, R. S., & Dempsey, W. H. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90536-5 · Cited by 123
Recombinant human erythropoietin and the anemia of cancer [editorial]
Spivak, J. (1994) · Blood · doi:10.1182/blood.v84.4.997.bloodjournal844997 · Cited by 121
Steensma, D. P., Sloan, J. A., Dakhil, S. R., Dalton, R. J., Kahanic, S. P., Prager, D. J., Stella, P. J., Rowland, K. M., Novotny, P. J., & Loprinzi, C. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3644 · Cited by 120
Impact of epoetin β on quality of life in patients with malignant disease
and the Epoetin β QOL Working Group, Boogaerts, M. A., Coiffier, B., & Kainz, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600801 · Cited by 119
for the Epoetin Alfa Study Group, Fallowfield, L. J., Gagnon, D. D., Zagari, M. J., Cella, D. F., Bresnahan, B. W., Littlewood, T. J., McNULTY, P. K., Gorzegno, G., & Freund, M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600657 · Cited by 117
Machtay, M. X., Pajak, T. F., Suntharalingam, M., Shenouda, G., Hershock, D. M., Stripp, D. C. H., Cmelak, A. J., Schulsinger, A., & Fu, K. K. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.063 · Cited by 114
O’Shaughnessy, J., Vukelja, S. J., Holmes, F. A., Savin, M. A., Jones, M., Royall, D. R., George, M. J., & Hoff, D. D. V. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.002 · Cited by 114
Pirker, R., Ramlau, R., Schuette, W., Zatloukal, P., Ferreira, I., Lillie, T., & Vansteenkiste, J. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0748 · Cited by 114
Epoetin and cognitive function.
Ar, N. (1992) · PubMed · Cited by 113
Ross, S. D., Allen, I. E., Henry, D. H., Seaman, C., Sercus, B., & Goodnough, L. T. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.06.003 · Cited by 111
Johnson, C. S., Cook, C. A., & Furmanski, P. (1990) · PubMed · Cited by 109
Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.
Thews, O., Kelleher, D. K., & Vaupel, P. W. (2001) · PubMed · Cited by 108
Cancer-related anemia: its causes and characteristics.
Spivak, J. (1994) · PubMed · Cited by 107
Schwartzberg, L. S., Yee, L., Senecal, F. M., Charu, V., Tomita, D. K., Wallace, J. F., & Rossi, G. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-696 · Cited by 104
Canon, J.-L. R., Vansteenkiste, J., Bodoky, G., Mateos, M., Bastit, L., Ferreira, I., Rossi, G., & Amado, R. G. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj053 · Cited by 103
Mantovani, L., Lentini, G., Hentschel, B., Wickramanayake, P. D., Loeffler, M., Diehl, V., & Tesch, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02016.x · Cited by 101
Recombinant Human Erythropoietin in the Treatment of the Anaemia of Cancer
Abels, R. (2009) · Acta Haematologica · doi:10.1159/000204780 · Cited by 98
Silver, D. F., & Piver, M. S. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5368 · Cited by 98
Razzouk, B. I., Hord, J. D., Hockenberry, M. J., Hinds, P. S., Feusner, J. H., Williams, D., & RACKOFF, W. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4371 · Cited by 98
Garton, J. P., Gertz, M. A., Witzig, T. E., Greipp, P. R., Lust, J. A., Schroeder, G., & Kyle, R. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.19.2069 · Cited by 96
Thompson, J. A., Gilliland, D. G., Prchal, J. T., Bennett, J. M., Larholt, K. M., Nelson, R. A., Rose, E. H., Dugan, M. H., & the GM/EPO MDS Study Group (2000) · Blood · doi:10.1182/blood.v95.4.1175.004k51_1175_1179 · Cited by 95
Arcasoy, M. O., Amin, K., Chou, S.-C., Haroon, Z. A., Varia, M. A., & Raleigh, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.20.11.1 · Cited by 95
The relationship between psychologic distress and cancer‐related fatigue
Tchekmedyian, N. S., Kallich, J. D., McDermott, A. M., Fayers, P. M., & Erder, M. H. (2003) · Cancer · doi:10.1002/cncr.11463 · Cited by 94
Biosimilar epoetins and other “follow‐on” biologics: Update on the European experiences
JELKMANN, W. E. B. (2010) · American Journal of Hematology · doi:10.1002/ajh.21805 · Cited by 94
The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events
Rosenzweig, M. Q., Bender, C. M., Lucke, J. P., Yasko, J. M., & Brufsky, A. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.06.010 · Cited by 93
Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
Abels, R. I., Larholt, K. M., Krantz, K. D., & Bryant, E. C. (1991) · Stem Cells · doi:10.1002/stem.5530090714 · Cited by 93
Glaspy, J. A., Jadeja, J., Justice, G. R., Fleishman, A. N., Rossi, G., & Colowick, A. B. (2003) · Cancer · doi:10.1002/cncr.11186 · Cited by 90
Glaspy, J. A., Henry, D. H., Patel, R., Tchekmedyian, S., Applebaum, S., Berdeaux, D. H., Lloyd, R., Berg, R., Austin, M., & Rossi, G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.021 · Cited by 90
Epoetin alfa improves quality of life in patients with cancer
Jones, M., Schenkel, B., Just, J., & Fallowfield, L. J. (2004) · Cancer · doi:10.1002/cncr.20569 · Cited by 89
Fusté, B., Serradell, M., Escolar, G., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613275 · Cited by 88
Prevalence of anemia in cancer patients undergoing radiation therapy
Harrison, L. C., Shasha, D., Shiaova, L., White, C. B., Ramdeen, B., & Portenoy, R. K. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90214-3 · Cited by 88
Grote, T. H., Yeilding, A., Castillo, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8507 · Cited by 85
Glaspy, J. A., Jadeja, J., Justice, G. R., Kessler, J., Richards, D., Schwartzberg, L. S., Rigas, J. R., Kuter, D. J., Harmon, D. C., Prow, D. M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1748 · Cited by 82
Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer.
Glimelius, B. L. G., Linné, T., Hoffman, K., Larsson, L., Svensson, J.-H., Näsman, P., Svensson, B., & Helmers, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.434 · Cited by 82
Kettelhack, C., Hönes, C., Messinger, D., & Schlag, P. M. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00564.x · Cited by 80
Glaspy, J. A., Vadhan‐Raj, S., Patel, R., Bosserman, L. D., Hu, E. H.-L., Lloyd, R. E., Boccia, R. V., Tomita, D. K., & Rossi, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8570 · Cited by 80
Cancer-Related Fatigue: Causes, Consequences, and Management
Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-1 · Cited by 79
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Lambin, P., Ramaekers, B. L. T., van Mastrigt, G. A. P. G., van den Ende, P. L. A., de Jong, J., Ruysscher, D. D., & Pijls-Johannesma, M. C. G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006158.pub2 · Cited by 78
Pierelli, L., Perillo, A., Greggi, S., Salerno, G., Panici, P. B., MENICHELLA, G., Fattorossi, A., Leone, G. G. M., Mancuso, S., & Scambia, G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1288 · Cited by 76
for the Aranesp® 990111 Study Group, Smith, R. E., Tchekmedyian, N. S., Chan, D., Meza, L., Northfelt, D., Patel, R., Austin, M., Colowick, A. B., Rossi, G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600994 · Cited by 75
Sweeney, P., Nicolae, D. L., Ignacio, L., Chen, L., Roach, M., Wara, W., Marcus, K. J., & Vijayakumar, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.331 · Cited by 72
Ross, S. D., Allen, I. E., Probst, C. A., Sercus, B., Crean, S. M., & Ranganathan, G. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1264 · Cited by 70
Quality‐of‐life and health benefits of early treatment of mild anemia
Straus, D. J., Testa, M. A., Sarokhan, B. J., Czuczman, M. S., Tulpule, A., Turner, R. R., & Riggs, S. A. (2006) · Cancer · doi:10.1002/cncr.22221 · Cited by 67
On the quality of treatment planning systems in radiation therapy.
Panten, T., Höss, A., Bohsung, J., Becker, G., & Sroka-Pérez, G. (1998) · PubMed · Cited by 67
Porter, J. C., Leahey, A., Polise, K., Bunin, G. R., & Manno, C. S. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70145-2 · Cited by 66
Preoperative Epoetin Alfa in Colorectal Surgery: A Randomized, Controlled Study
Christodoulakis, M., & Tsiftsis, D. D. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.06.031 · Cited by 65
Barosi, G., Bosi, A., Abbracchio, M. P., Danesi, R., Genazzani, A. A., Corradini, P., Pane, F., & Tura, S. (2011) · Haematologica · doi:10.3324/haematol.2011.041210 · Cited by 63
Kimel, M., Leidy, N. K., Mannix, S., & Dixon, J. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00215.x · Cited by 62
Hedenus, M., Vansteenkiste, J., Kotasek, D., Austin, M., & Amado, R. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.434 · Cited by 61
Engert, A., Josting, A., Haverkamp, H., Villalobos, M., Lohri, A., Sökler, M., Zijlstra, J. M., Sturm, I., Topp, M. S., Rank, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1835 · Cited by 59
Self-citationJ-E. Johansson, P. W. (2001) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655901750425864 · Cited by 59
Hoskin, P., Robinson, M., Slevin, N. J., Morgan, D., Harrington, K. J., & Gaffney, C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3693 · Cited by 58
Lavey, R. S., Liu, P. Y., Greer, B. E., Robinson, W. R., Chang, P. C., Wynn, R. B., Conrad, M. E., Jiang, C. S., Markman, M. M., & Alberts, D. S. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.009 · Cited by 58
Österborg, A., Brandberg, Y., & Hedenus, M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05440.x · Cited by 57
Psychological outcomes associated with anemia-related fatigue in cancer patients.
Kallich, J. D., Tchekmedyian, N. S., Damiano, A. M., Shi, J., Black, J. T., & Erder, M. H. (2002) · PubMed · Cited by 57
Changing patterns of care in the management of anemia.
Henry, D. H. (1992) · PubMed · Cited by 57
Aapro, M., Cella, D. F., & Zagari, M. J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70175-9 · Cited by 56
Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?
Bottomley, A., Thomas, R., Steen, K. V., Flechtner, H., & Djulbegović, B. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00677-0 · Cited by 54
Scott, S. N., Boeve, T. J., McCulloch, T. M., Fitzpatrick, K. A., & Karnell, L. H. (2002) · The Laryngoscope · doi:10.1097/00005537-200207000-00015 · Cited by 54
Kurz, C., Marth, C., Windbichler, G. H., et al. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4675 · Cited by 54
Significance of Hemoglobin Concentration for Treatment Outcome
Grau, C., & Overgaard, J. (2000) · Medical radiology · doi:10.1007/978-3-642-58813-6_10 · Cited by 54
Erythroid-Stimulating Agents in Cancer Therapy: Potential Dangers and Biologic Mechanisms
Hadland, B., & Longmore, G. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6945 · Cited by 53
Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma
Silvestris, F., Romito, A., Fanelli, P., Vacca, A., & Dammacco, F. (1995) · Annals of Hematology · doi:10.1007/bf01696618 · Cited by 52
Kunikane, H., Watanabe, K., Fukuoka, M., Furuse, K., Ikegami, H., Ariyoshi, Y., Kishimoto, S., & Saijo, N. (2001) · International Journal of Clinical Oncology · doi:10.1007/s10147-001-8031-y · Cited by 52
Aapro, M., Osterwalder, B., Scherhag, A. W., & Burger, H.-U. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605255 · Cited by 52
Bamias, A., Aravantinos, G., Kalofonos, H. P., Timotheadou, N., Siafaka, V., Vlahou, I., Janinis, D., Pectasides, D., Pavlidis, N. A., & Fountzilas, G. (2003) · Oncology · doi:10.1159/000067766 · Cited by 51
for the EPO-INT-45 Study Group, Wilkinson, P. M., Antonopoulos, M., Lahousen, M., Lind, M., & Kosmidis, P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603004 · Cited by 49
Littlewood, T. J., Nortier, J. W. R., Rapoport, B. L., Pawlicki, M., Wasch, G. D., Vercammen, E., Schuette, W., Wils, J., & Freund, M. (2003) · Hematological Oncology · doi:10.1002/hon.722 · Cited by 48
Dammacco, F., Silvestris, F., Castoldi, G., Grassi, B., Bernasconi, C., Nadali, G., Perona, G., Laurenzi, A. D., Torelli, U. L., Ascari, E., et al. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050032 · Cited by 48
Małyszko, J. S., Małyszko, J. S., Małyszko, J. S., et al. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)91619-v · Cited by 48
Pathophysiology of cancer-related anemia
Nowrousian, M. R. (2002) · Springer eBooks · doi:10.1007/978-3-7091-7658-0_3 · Cited by 46
Blohmer, J., Paepke, S., Sehouli, J., Boehmer, D., KOLBEN, M., Würschmidt, F., Petry, K. U., Kimmig, R., Elling, D., Thomssen, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.4899 · Cited by 45
Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer
Abels, R. I., Larholt, K. M., Krantz, K. D., & Bryant, E. C. (1996) · The Oncologist · doi:10.1634/theoncologist.1-3-140 · Cited by 44
Wurnig, C., Windhager, R., Schwameis, E., Kotz, R. I., Zoubek, A., Stockenhuber, F., & Kurz, R. W. (1996) · Transfusion · doi:10.1046/j.1537-2995.1996.36296181929.x · Cited by 43
Dahl, N. V., Henry, D. H., & Coyne, D. W. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00435.x · Cited by 42
Savonije, J. H., van Groeningen, C. J., van Bochove, A., Honkoop, A. H., van Felius, C. L., Wormhoudt, L. W., & Giaccone, G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.024 · Cited by 42
Littlewood, T. J., Kallich, J. D., Miguel, J. F. S., Hendricks, L., & Hedenus, M. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.08.013 · Cited by 42
Erythropoietin, uncertainty principle and cancer related anaemia
Clark, O. A. C., Adams, J. R., Bennett, C. L., & Djulbegović, B. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-23 · Cited by 42
Cited by
Batchelor, T. J. P., Rasburn, N. J., Abdelnour-Berchtold, E., Brunelli, A., Cerfolio, R. J., Gonzalez, M., Ljungqvist, O., Petersen, R. H., Popescu, W. M., Slinger, P. D., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy301 · Cited by 1,366
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731
Nelson, G., Altman, A. D., Nick, A., Meyer, L. A., Ramirez, P. T., Achtari, C., Antrobus, J., Huang, J., Scott, M., Wijk, L., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.12.019 · Cited by 562
Metadata
- Authors
- Tonia, T., Mettler, A., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., & Bohlius, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-12-12
- Volume
- 2012
- Issue
- 12
- Pages
- CD003407-CD003407
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2111324822
- Cited by
- 392
- References
- 267
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.